cost comparison glp 1 GLP-1 Agonists: Managing Employee Health and Employer Costs Perspectives from employers on the
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a breakthrough in medically controlled weight loss
While GLP-1RA has proven clinical efficacy, the need for more comprehensive studies, to ensure their long-term safety, is essential to optimize their therapeutic role and improve patient outcomes on a global scale

Supports weight management while protecting lean mass Along with the lean mass increase mentioned in the study above, using 1-2 Glucerna servings as partial meal replacements over 90 days also led 2 x greater weight loss of visceral adipose tissue (belly fat) +8 3

Oral GLP-1 agonists, led by oral Semaglutide, are gaining momentum as they offer greater convenience and patient adherence

Luo X, Hu Y, He S, Ye Q, Lv Z, Liu J, Chen X